CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $597,743 | -9.7% | 20,290 | -0.0% | 0.01% | 0.0% |
Q2 2023 | $662,023 | +119614.8% | 20,295 | +29.2% | 0.01% | +25.0% |
Q1 2023 | $553 | -23.4% | 15,705 | -0.4% | 0.00% | -33.3% |
Q4 2022 | $722 | -99.9% | 15,765 | -0.6% | 0.01% | 0.0% |
Q3 2022 | $755,000 | +22.4% | 15,865 | +1.0% | 0.01% | +20.0% |
Q2 2022 | $617,000 | +37.4% | 15,710 | +28.7% | 0.01% | +66.7% |
Q1 2022 | $449,000 | -8.6% | 12,210 | -17.5% | 0.00% | -25.0% |
Q4 2021 | $491,000 | +8.1% | 14,795 | +16.5% | 0.00% | +33.3% |
Q3 2021 | $454,000 | +116.2% | 12,700 | +19.6% | 0.00% | +200.0% |
Q2 2021 | $210,000 | -15.0% | 10,620 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $247,000 | +38.0% | 10,620 | +23.5% | 0.00% | +100.0% |
Q4 2020 | $179,000 | -16.7% | 8,600 | -13.6% | 0.00% | -50.0% |
Q3 2020 | $215,000 | +16.8% | 9,950 | +27.6% | 0.00% | 0.0% |
Q2 2020 | $184,000 | +109.1% | 7,800 | +4.0% | 0.00% | +100.0% |
Q1 2020 | $88,000 | +10.0% | 7,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $80,000 | – | 7,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |